Clinical Trial Site
Hamburg 22763
1 studies enrolling now · 3 studies all time
What they study most
ANCA-Associated Vasculitis, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Primary Hyperoxaluria Type 1
Studies at this site
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
- BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) — Running, not enrolling
- A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed